Moderate Immunohistochemical Expression of HER-2 (2+) Without HER-2 Gene Amplification Is a Negative Prognostic Factor in Early Breast Cancer

by Rossi, Valentina, Sarotto, Ivana, Maggiorotto, Furio, Berchialla, Paola, Kubatzki, Franziska, Tomasi, Nicoletta, Redana, Stefania, Martinello, Rossella, Valabrega, Giorgio, Aglietta, Massimo, Ponzone, Riccardo, Montemurro, Filippo
Published 2012

Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study

by Geuna, Elena, Lombardi, Pasquale, Martinello, Rossella, Garino, Davide, Bonzano, Alessandro, Galizia, Danilo, Nuzzo, Annamaria, Berchialla, Paola, Becco, Paolo, Mangioni, Monica, De Zarlo, Lorena, Montemurro, Filippo
Published in Cancers (Basel) (2020)

Should All Patients With HR-Positive HER2-Negative Metastatic Breast Cancer Receive CDK 4/6 Inhibitor As First-Line Based Therapy? A Network Meta-Analysis of Data from the PALOMA 2...

by Rossi, Valentina, Berchialla, Paola, Giannarelli, Diana, Nisticò, Cecilia, Ferretti, Gianluigi, Gasparro, Simona, Russillo, Michelangelo, Catania, Giovanna, Vigna, Leonardo, Mancusi, Rossella Letizia, Bria, Emilio, Montemurro, Filippo, Cognetti, Francesco, Fabi, Alessandra
Published in Cancers (Basel) (2019)

Self‐evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study

by Galizia, Danilo, Milani, Andrea, Geuna, Elena, Martinello, Rossella, Cagnazzo, Celeste, Foresto, Manuela, Longo, Virginia, Berchialla, Paola, Solinas, Gianfranca, Calori, Adele, Grasso, Bruna, Volpone, Chiara, Bertola, Gisella, Parola, Gisella, Tealdi, Giancarla, Giuliano, Piero Luigi, Ballari, Anna Maria, Aglietta, Massimo, Montemurro, Filippo
Published in Cancer Med (2018)